Klacid/Klacid MR Indications/Uses

Klacid/Klacid Forte: Klacid is indicated for treatment of infections caused by one or more susceptible organisms in adults and children 12 years and older. Indications include: 1. Lower respiratory tract infections for example, acute and chronic bronchitis, and pneumonia (see Precautions and Microbiology under Actions regarding Sensitivity Testing).
2. Upper respiratory tract infections for example, sinusitis and pharyngitis.
3. Klacid is appropriate for initial therapy in community acquired respiratory infections and has been shown to be active in vitro against common and atypical respiratory pathogens as listed in Microbiology under Actions.
Klacid is also indicated in skin and soft tissue infections of mild to moderate severity (see Precautions and Microbiology under Actions regarding Sensitivity Testing).
Klacid in the presence of acid suppression effected by omeprazole is also indicated for the eradication of H. pylori in patients with proven duodenal ulcers. See Dosage & Administration.
Klacid MR: Klacid MR is indicated for treatment of infections caused by susceptible organisms. Indications include: Lower respiratory tract infections for example, acute and chronic bronchitis, and pneumonia (see Precautions and Microbiology under Actions regarding Sensitivity Testing).
Upper respiratory tract infections for example, sinusitis and pharyngitis.
Klacid MR is also indicated in skin and soft tissue infections of mild to moderate severity, for example folliculitis, cellulitis and erysipelas (see Precautions and Microbiology under Actions regarding Sensitivity Testing).
Klacid Pediatric Suspension: Klacid Pediatric Suspension is indicated for treatment of infections due to susceptible organisms in children 6 months to 12 years, in the following conditions: 1. Upper respiratory infections (e.g., streptococcal pharyngitis).
2. Lower respiratory infections (e.g., bronchitis, pneumonia) (see Precautions and Microbiology under Actions under Sensitivity Testing).
3. Acute otitis media.
4. Skin and skin structure infections (e.g., impetigo, folliculitis, cellulitis, abscesses) (see Precautions and Microbiology under Actions regarding Sensitivity Testing).
5. Disseminated or localized mycobacterial infections due to Mycobacterium avium or Mycobacterium intracellulare. Localized infections due to Mycobacterium chelonae, Mycobacterium fortuitum, or Mycobacterium kansasii.
Klacid IV: Klacid I.V. is indicated whenever parenteral therapy is required for treatment of sensitive microorganisms in adults 18 years and older in the following conditions: 1. Upper respiratory tract infections.
2. Lower respiratory tract infections (see Precautions and Microbiology under Actions regarding Sensitivity Testing).
3. Skin and soft tissue infections (see Precautions and Microbiology under Actions regarding Sensitivity Testing).
4. Disseminated or localized mycobacterial infections due to Mycobacterium avium or Mycobacterium intracellulare. Localized infections due to Mycobacterium chelonae, Mycobacterium fortuitum, or Mycobacterium kansasii.
Consideration should be given to national official guidance on the appropriate use of antibacterial agents.